My research interest is to understand the role of the microbiome in stroke, with a focus on intestinal immune function and microbial metabolites.
My scientific goal is to better understand how the gut microbiome may influence stroke outcome and post-stroke comorbidities. Modulation of the microbiome–specially which kind of metabolites our gut bacteria produce–may have strong therapeutic implications in stroke by diet interventions.
1st international Stroke–Immunology conference 2020
Munich, Apr 1–3 2010. “Adaptive immunity and recovery”
Society for Neuroscience (SfN) 2019
Chicago, Oct 19–23 2019. “The gut-brain axis in health and brain disease”
Brain & Brain PET Conference 2019
Yokohama July 4–7 2019. “The role of the microbiome in acute and chronic brain disease”
AIRS: International Conference and Exhibition on Genomics and Microbiomics
Amsterdam Jan 17–18 2019.
“The bi-directional communication between gut and brain after stroke”
International Stroke Conference 2019
American Stroke Association.
Hawaii Feb 6–8 2019. “Microbiome in stroke and heart diseases”
“When not working in the lab or writing grants, my passion is to design scientific illustrations.”
Contact me if you would like a graphical abstract for your new research paper !
Stroke | Microbiome
My research focuses on how the gut microbiota can modify the immune response to a stroke and ameliorate stroke outcome and comorbidities.
Corinne Benakis, PhD
Institute for Stroke and Dementia Research (ISD)
Klinikum der Universität München
Feodor-Lynen-Straße 17, D-81377 Munich, Germany